Treat-to-target

Semmelweis researchers want depression and sleep checked before rheumatoid arthritis drugs are escalated

Semmelweis researchers say depression, poor sleep, obesity and smoking may sustain symptoms in the 6-28% of rheumatoid arthritis cases that resist treatment. They want doctors to look for those causes before escalating drugs when inflammation markers improve but pain and fatigue persist.